Cbl, IRS-1, and IRS-2 mediate effects of rosiglitazone on PI3K, PKC-lambda, and glucose transport in 3T3/L1 adipocytes.

Source:http://linkedlifedata.com/resource/pubmed/id/11956152

Download in:

View as

General Info

PMID
11956152